3Gerber PA,Antal AS,Neumann NJ,et aI.Neurofibromatosis[J].Eur J Med Res.2009,17;14(3):102-105.
4National Institutes of Health Consensus Development Conference Statement: Neurofibromatosis [J]. Arch Neurol Chicago, 1988,45: 575-578.
5Ruggierei M, Huson SM. The clinical and diagnostic implications of mosaicism in the neurofibromatosis [J]. Neurology, 2001,56: 1433-1443.
6De Luca A, Bottiloo I, Sarkozy A, et al. NF1 gene mutations represent the major molecular event underlying neurofibromatosis- Noonan syndrome [J]. Am .I Med Genet, 2005,77:1092-1101.
7Trofatter J, MacCollin M, Rutter JL, et al. A novel moesin-esrinradixin-like gene is a candidate for the neurofibromatosis 2 turnouts suppressor[J]. Cell, 1993,72:791-800.
8MacCollin M, Chiocca EA, Evans DG, et al. Diagnostic criteria for schwannomatosis [J]. Neurology, 2005,64:1838-1845.
9Korf BR. Plexiform neurofibromas [J]. Am J Med Genet, 1999,89: 31-37.
10Ferner RE, Huson SM, Thomas N, et al. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1 [J]. J Med Genet, 2007,44:81-88.
